MABE1033MI

MilliporeSigma™ Mouse anti-SMARCB1, Clone: 2C2,

Manufacturer: MilliporeSigma™

Select a Size

Pack Size SKU Availability Price
Each of 1 MABE1033MI-Each-of-1 In Stock ₹ 39,160.00

MABE1033MI - Each of 1

₹ 39,160.00

In Stock

Quantity

1

Base Price: ₹ 39,160.00

GST (18%): ₹ 7,048.80

Total Price: ₹ 46,208.80

Antigen

SMARCB1

Classification

Monoclonal

Formulation

Purified mouse monoclonal IgG2aκ in buffer containing 0.1M Tris-Glycine (pH 7.4), 150mM NaCl with 0.05% sodium azide.

Gene Symbols

SMARCB1; BAF47; INI1; SNF5L1

Immunogen

GST-tagged recombinant protein corresponding to human SMARCB1.

Quantity

100 μg

Research Discipline

Epigenetics and Nuclear Function

Gene ID (Entrez)

NP_001007469

Content And Storage

Stable for one year at 2°C to 8°C from date of receipt.

Isotype

IgG2a κ

Applications

Immunocytochemistry, Western Blot

Clone

2C2

Gene Accession No.

Q12824

Host Species

Mouse

Purification Method

Protein G Purified

Regulatory Status

RUO

Primary or Secondary

Primary

Target Species

Human

Form

Purified

Related Products

Img

MilliporeSigma™

MABE903MI

--

Img

MilliporeSigma™

MABE1039MI

--

Img

MilliporeSigma™

MABE897MI

--

Img

MilliporeSigma™

MABC565MI

--

Img

MilliporeSigma™

MABE443MI

--

Img

MilliporeSigma™

MABE1043MI

--

Img

MilliporeSigma™

MABE1040MI

--

Img

MilliporeSigma™

MABE988MI

--

Description

  • Specifically detects SMARCB1 clone: 2C2 in Human samples, and it is validated for Immunocytochemistry, Western Blotting SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (SMARCB1), also known as BRG1-associated factor 47 (BAF47) or Integrase interactor 1 protein or SNF5 homolog (hSNF5), and encoded by the gene name SMARCB1 or BAF47, is part of a complex that relieves repressive chromatin structures, allowing the transcriptional machinery to access its targets more effectively
  • The encoded nuclear protein has also been shown to bind to and enhance the DNA joining activity of HIV-1 integrase
  • It has been found to be a tumor suppressor, and the loss of SMARCB1 has been associated with malignant rhabdoid tumors
  • Tumor cells of synovial sarcoma seem to have a post transcriptional regulatory mechanism for SMARCB1.